共 421 条
[1]
Sung H(2021)Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-249
[2]
Ferlay J(2019)Optimizing the outcomes of pancreatic cancer surgery Nat Rev Clin Oncol 16 11-26
[3]
Siegel RL(2021)Pancreatic cancer: a review JAMA 326 851-862
[4]
Laversanne M(2021)Immune checkpoint inhibitors in melanoma Lancet 398 1002-1014
[5]
Soerjomataram I(2021)Toward personalized treatment approaches for non-small-cell lung cancer Nat Med 27 1345-1356
[6]
Jemal A(2010)Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma J Immunother 33 828-833
[7]
Bray F(2012)Safety and activity of anti-PD-L1 antibody in patients with advanced cancer N Engl J Med 366 2455-2465
[8]
Strobel O(2020)BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial Nat Med 26 878-885
[9]
Neoptolemos J(2021)CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study Lancet Oncol 22 118-131
[10]
Jager D(2017)Hypermutation in pancreatic cancer Gastroenterology 152 68-74.e62